Arcus Biosciences (NYSE:RCUS) said on Thursday that its experimental drug candidate, quemliclustat, has received orphan drug status from the U.S. FDA. Quemliclustat is a type of medication that works ...

Arcus Biosciences (RCUS) presented new data for casdatifan, a HIF-2a inhibitor with best-in-class potential, in an oral plenary session by Dr. T ...

In this article, learn about arcus senilis. What are the risk factors, how is it diagnosed, how is it linked to high cholesterol, and can it be treated? Learn more.

Hayward, CA-based Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage biopharmaceutical company with a market capitalization of $1.29 billion and a strong financial health rating according to ...

“Arcus stands out as a mid-sized biotech company with its breadth and depth of oncology assets and entry into inflammation and immunology; it’s an exciting time to be joining the ...

Arcus Biosciences appoints new Chief Medical OfficerIn other recent news, Arcus Biosciences, during its third-quarter 2024 earnings call, discussed financial results and advancements in its ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

HAYWARD, Calif., January 21, 2025--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies ...

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer Dr. Markus will oversee Arcus’s clinical development organization and portfolio that includes seven clinical-stage ...

First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer ...

Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers ...

The Centre on Monday defended the change in the National Medical Commission's logo to feature Dhanwantari -- the physicians of the Gods in Hindu mythology -- instead of a secular emblem, saying it ...